Impact by Sector

 Fisheries:

 1)  CETA: Time to admit it's an underhanded oversold deal 
 (Dec. 15th, 2014)

The squabble between the federal and provincial governments over the $280 million MPR package is an opportunity to revisit what we’ve been asked to give up under CETA, and just what we’re getting in return. Click here for details.

The squabble between the federal and provincial governments over the $280 million MPR package is an opportunity to revisit what we’ve been asked to give up under CETA, and just what we’re getting in return. - See more at: http://theindependent.ca/2014/12/15/ceta-time-to-admit-its-an-oversold-underhanded-deal/#sthash.9Bu2SfH5.dpuf
2) Yes, there are goodies for the fisheries in CETA. But let’s look deeper 
(Nov. 19th, 2013)
 
Tariff removal on shell fish products is great. Trouble is, it may not be only minimum processing we’ve given up. Click here to find out why our control of the fisheries might be at risk under CETA. 

Here's the series of letters between the federal and provincial governments that led to the abandonment of Minimum Processing Requirements.  

http://www.assembly.nl.ca/business/electronicdocuments/Canada-EUComprehensiveEconomicTradeAgreement-CETA.pdf

Agriculture:

What do farmers gain and lose with CETA?

Learn why the National Farmers Union, the organization that represents Canadian family farmers,  is opposed to CETA. Find out why the supposedly impressive market access negotiated for agricultural products may not be what it seems. Click here to learn more.

Manufacturing:

CETA will reinforce comparative advantage. That’s bad for Canadian manufacturing.

The largest obstacles to increasing Canadian exports of manufactured products to the European Union, including automobiles, are not tariff related. Click here to learn more.

Pharmaceuticals:

Big Pharma gets Bigger under CETA.

Canada has caved into EU demands to create a new system of patent term extension that will add up to two years of monopoly protection to brand-name drugs. Click here to learn more about the anticipated impact on health care spending, citizens, and Canadian businesses.